Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2003
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315793A1 Methods for culturing human lung mast cells and uses thereof
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315736A2 Nucleoside derivatives for the treatment of hepatitis c
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315723A1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
06/04/2003EP1315715A1 Quinazoline derivatives as kinase inhibitors
06/04/2003EP1315710A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315709A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315708A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315704A1 2-guanidino-4-aryl-quinazoline
06/04/2003EP1315700A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
06/04/2003EP1315537A1 Method and system for myocardial infarction repair
06/04/2003EP1315514A2 Methods and compositions for producing a neurosalutary effect in a subject
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315508A1 Purine ribosides as antiarrhythmics
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315499A1 Compositions and methods for the treatment of anorectal disorders
06/04/2003EP1315482A2 Water-dispersible encapsulated sterols
06/04/2003EP1315476A2 Nitric oxide-producing hydrogel materials
06/04/2003EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1232156B1 [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1165543B1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP1140186B1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
06/04/2003EP1140185B1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
06/04/2003EP1140184B1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
06/04/2003EP1121121B1 Methods for inhibiting diabetic complications
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP1027363B1 Adenosine a1-receptor agonists
06/04/2003EP0973790B1 Estra-5(10),7-dienes with estrogenic activity
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422268A 5-alkylpyrido [2,3-D] pyrimidines tyrosine kinase inhibitors
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422245A Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril
06/04/2003CN1422230A Infusion packet with useful and decorative element, support member, delivery system and method
06/04/2003CN1422161A New combination of a beta blocker and a cholesterol-lowering agent
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1422153A Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
06/04/2003CN1422152A Combination of organic compound
06/04/2003CN1422150A Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
06/04/2003CN1421242A Compound red sage capsule for treating cardiac and cerebral vascular diseases and its prepn process
06/04/2003CN1421241A Compound red sage drip pill for treating cardiac and cerebral vascular diseases and its prepn process
06/04/2003CN1421239A Compound red sage prepn for treating cardiac and cerebral vascular diseases and its prepn process
06/04/2003CN1421238A Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
06/04/2003CN1421228A Tea, medicated tea and buccal tablet for lowering blood pressure and reducing blood fat and their prepn process
06/04/2003CN1421226A Application of Hibiscus sabdariffa Linn extractive in preparing medicine for inhibiting cardiac and cerebral vascular diseases
06/04/2003CN1421215A Health care composition for preventing and treating cadiac vascular diseases and its use
06/04/2003CN1421210A Cell growth regulating factor P and its prepn process
06/04/2003CN1421208A Compound prepn containing alpha-linolic acid, lecithin and ginkgetin
06/04/2003CN1421207A Control released osmotic pump prepn containing ligustrazine phosphate and its prepn process
06/04/2003CN1110501C Cholesterol acetate extracted from sponge and its preparation
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/04/2003CN1110494C Novel active benzothiepines having inhibitors forileal bile acid transfer and taurocholate salt adsorption
06/04/2003CN1110493C Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
06/04/2003CN1110490C Sulfamide-substituted condensed seven-membered ring compound, used as medicine and medical preparation containing the same
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110304C Slow-release medicine composition for oral administration containing nifedipine as active substance
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573383 Preparing anhydrous (2R,4S)-4-((3,5-bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester by dissolving in heptanes or water and polar solvent and drying
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573293 Anticancer agents
06/03/2003US6573288 Compounds are inhibitors of the sodium-dependent bicarbonate/chloride ion exchanger which can be used as medicines for the prophylaxis or treatment of a wide range of diseases, for example the treatment and/or prophylaxis of
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573279 Isoquinoline derivatives or salts thereof
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573270 Endothelin receptor antagonists